HUTCHMED (China) Limited
HCM
$12.20
$0.040.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.22% | 0.22% | -16.54% | -16.54% | -9.16% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.22% | 0.22% | -16.54% | -16.54% | -9.16% |
| Cost of Revenue | -3.60% | -3.60% | -16.75% | -16.75% | 32.99% |
| Gross Profit | 24.24% | 24.24% | 17.94% | 17.94% | -69.64% |
| SG&A Expenses | 11.66% | 11.66% | 11.44% | 11.44% | -28.00% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.34% | -1.34% | -10.04% | -10.04% | -15.61% |
| Operating Income | 124.73% | 124.73% | -120.25% | -120.25% | 87.23% |
| Income Before Tax | -96.64% | -96.64% | -83.91% | -83.91% | 1,685.54% |
| Income Tax Expenses | -98.09% | -98.09% | -89.60% | -89.60% | 2,088.57% |
| Earnings from Continuing Operations | -96.43% | -96.43% | -81.87% | -81.87% | 1,641.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 47.75% | 47.75% | -188.31% | -188.31% | -65.11% |
| Net Income | -96.50% | -96.50% | -83.61% | -83.61% | 1,663.32% |
| EBIT | 124.73% | 124.73% | -120.25% | -120.25% | 87.23% |
| EBITDA | 204.95% | 204.95% | -181.88% | -181.88% | 112.24% |
| EPS Basic | -96.53% | -96.53% | -84.29% | -84.29% | 1,657.62% |
| Normalized Basic EPS | -58.50% | -58.50% | -96.10% | -96.10% | 41.35% |
| EPS Diluted | -96.46% | -96.46% | -98.00% | -98.00% | 1,633.33% |
| Normalized Diluted EPS | -57.64% | -57.64% | -96.00% | -96.00% | 41.18% |
| Average Basic Shares Outstanding | 1.02% | 1.02% | 0.57% | 0.57% | 0.12% |
| Average Diluted Shares Outstanding | 0.03% | 0.03% | 0.01% | 0.01% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |